XML Feed for RxPG News   Add RxPG News Headlines to My Yahoo!   Javascript Syndication for RxPG News

Research Health World General
 
  Home
 
 Latest Research
 Cancer
  Breast
  Skin
  Blood
  Prostate
  Liver
  Colon
  Thyroid
  Endometrial
  Brain
  Therapy
  Risk Factors
  Esophageal
  Bladder
  Lung
   Small Cell Carcinoma
  Rectal Cancer
  Pancreatic Cancer
  Bone Cancer
  Cervical Cancer
  Testicular Cancer
  Gastric Cancer
  Ovarian Cancer
  Nerve Tissue
  Renal Cell Carcinoma
 Psychiatry
 Genetics
 Surgery
 Aging
 Ophthalmology
 Gynaecology
 Neurosciences
 Pharmacology
 Cardiology
 Obstetrics
 Infectious Diseases
 Respiratory Medicine
 Pathology
 Endocrinology
 Immunology
 Nephrology
 Gastroenterology
 Biotechnology
 Radiology
 Dermatology
 Microbiology
 Haematology
 Dental
 ENT
 Environment
 Embryology
 Orthopedics
 Metabolism
 Anaethesia
 Paediatrics
 Public Health
 Urology
 Musculoskeletal
 Clinical Trials
 Physiology
 Biochemistry
 Cytology
 Traumatology
 Rheumatology
 
 Medical News
 Health
 Opinion
 Healthcare
 Professionals
 Launch
 Awards & Prizes
 
 Careers
 Medical
 Nursing
 Dental
 
 Special Topics
 Euthanasia
 Ethics
 Evolution
 Odd Medical News
 Feature
 
 World News
 Tsunami
 Epidemics
 Climate
 Business
Search

Last Updated: Aug 19th, 2006 - 22:18:38

Archives of Internal Medicine

Lung Channel
subscribe to Lung newsletter

Latest Research : Cancer : Lung

   DISCUSS   |   EMAIL   |   PRINT
Tumor diameter - an important prognostic indicator for curability
Feb 15, 2006, 14:55, Reviewed by: Dr. Rashmi Yadav

"Most lung cancers without evidence of lymph node metastases are curable, with the curability rate being higher at smaller sizes."

 
Smaller tumors in the lungs appear to be less likely to have spread than larger tumors among patients with asymptomatic lung cancer, suggesting that early screening may be useful in detecting cancers that are still curable, according to a new article in the February 13 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

Cancers in the earliest stage, which have not yet spread beyond the lungs, are divided by size into stage IA (tumors less than 30 millimeters in diameter) and stage IB (tumors larger than 30 millimeters in diameter), according to background information in the article. The development of computed tomography (CT) scanning has allowed physicians to detect lung tumors at a smaller size, prompting some to call for more subdivisions of stage I cancers. Though tumor size has been linked to cancer prognosis in patients with symptoms, the relationship between tumor size, metastasis (cancer spread) and prognosis in asymptomatic individuals has been unclear, the authors write.

Claudia I. Henschke, M.D., Ph.D., New York Presbyterian Hospital-Weill Cornell Medical Center, New York, and colleagues from the International Early Lung Cancer Action Program screened 28,689 men and women for lung cancer at 38 institutions worldwide between 1993 and 2004. Four hundred sixty-four patients were diagnosed with lung cancer as the result of the screening. The researchers classified the participants' lung cancers based on their type-small cell or non-small cell-as well as the size (diameter) of their tumors at diagnosis and whether or not they had metastasized. They also recorded the consistency of the tumors as solid, nonsolid or part-solid.

For the 436 patients with non-small cell cancers, which are less aggressive than small-cell cancers, the likelihood of metastasis increased along with tumor size. When the researchers analyzed the tumors by consistency, they found the association strongest for solid tumors, weaker for part-solid tumors and not apparent for nonsolid tumors. For the few (28) cases of small cell cancer, the relationship appeared strong for those tumors as well. The percentages of nonmetastasized cancer of all types were much higher than those reported in previous studies.

"The pattern confirmed herein suggests the usefulness of finding latent cancers at small sizes," the authors conclude. "Most lung cancers without evidence of lymph node metastases are curable, with the curability rate being higher at smaller sizes. This suggests that tumor diameter also serves as a prognostic indicator for curability, perhaps even for micrometastases not detectable by our current techniques."
 

- The article appears in the February 13 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.
 

http://jama.ama-assn.org/

 
Subscribe to Lung Newsletter
E-mail Address:

 

(Arch Intern Med. 2006; 166: 321-325)


Related Lung News

Gene Expression Profiling Not Quite Perfected in Predicting Lung Cancer Prognosis
I-ELCAP study: Lung cancer can be detected early with annual low-dose CT screening
Key to lung cancer chemotherapy resistance revealed
3D-CRT brings hope for inoperable lung cancers
Sunitinib Malate shows promise against advanced form of lung cancer
Tarceva-Celebrex Combination therapy shows promising results in advanced lung cancer
Lung cancer susceptibility runs in families - Study
Do Variants in the GST Detoxification Genes Affect the Risk of Lung Cancer?
Tumor diameter - an important prognostic indicator for curability
Palliative radiation can cure some NSCLC


For any corrections of factual information, to contact the editors or to send any medical news or health news press releases, use feedback form

Top of Page

 

© Copyright 2004 onwards by RxPG Medical Solutions Private Limited
Contact Us